{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:22:30Z","timestamp":1790785350203,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Haleon, formerly GSK Consumer Healthcare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40122-025-00723-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:46:11Z","timestamp":1743741971000},"page":"1007-1024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch"],"prefix":"10.1007","volume":"14","author":[{"given":"Nicholas M.","family":"Sicignano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique Bariguian","family":"Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Petruschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis P.","family":"Barbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess D.","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"10267","key":"723_CR1","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/S0140-6736(20)32340-0","volume":"396","author":"A Cieza","year":"2021","unstructured":"Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2021;396(10267):2006\u201317.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"723_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/acr.20200","volume":"62","author":"AS Buchman","year":"2010","unstructured":"Buchman AS, Shah RC, Leurgans SE, Boyle PA, Wilson RS, Bennett DA. Musculoskeletal pain and incident disability in community-dwelling older adults. Arthritis Care Res. 2010;62(9):1287\u201393.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"723_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008;58(1):26\u201335.","journal-title":"Part II Arthritis Rheum"},{"issue":"2","key":"723_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheum (Hoboken, NJ). 2020;72(2):220\u201333.","journal-title":"Arthritis Rheum (Hoboken, NJ)"},{"key":"723_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40122-021-00235-2","volume":"10","author":"SN El-Tallawy","year":"2021","unstructured":"El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JA, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021;10:181\u2013209.","journal-title":"Pain Ther"},{"key":"723_CR6","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.3389\/jpps.2024.12384","volume":"27","author":"SM Weisman","year":"2024","unstructured":"Weisman SM, Ciavarra G, Cooper G. What a pain in the\u2026 back: a review of current treatment options with a focus on naproxen sodium. J Pharm Pharm Sci. 2024;27:12384.","journal-title":"J Pharm Pharm Sci"},{"issue":"9","key":"723_CR7","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.3390\/jcm11092609","volume":"11","author":"R Bonanni","year":"2022","unstructured":"Bonanni R, Cariati I, Tancredi V, Iundusi R, Gasbarra E, Tarantino U. Chronic pain in musculoskeletal diseases: Do you know your enemy? J Clin Med. 2022;11(9):2609.","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"723_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40266-019-00660-1","volume":"36","author":"C Cooper","year":"2019","unstructured":"Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruy\u00e8re O, Rannou F, et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl 1):15\u201324.","journal-title":"Drugs Aging"},{"issue":"8","key":"723_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ddr.22118","volume":"84","author":"SY Ewieda","year":"2023","unstructured":"Ewieda SY, Ahmed EM, Hassan RA, Hassan MS. Pyridazine derivatives as selective COX-2 inhibitors: A review on recent updates. Drug Dev Res. 2023;84(8):1595\u2013623.","journal-title":"Drug Dev Res"},{"issue":"1","key":"723_CR10","doi-asserted-by":"publisher","first-page":"2281262","DOI":"10.1080\/14756366.2023.2281262","volume":"38","author":"WA Fadaly","year":"2023","unstructured":"Fadaly WA, Zidan TH, Kahk NM, Mohamed FE, Abdelhakeem MM, Khalil RG, et al. New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. J Enzyme Inhib Med Chem. 2023;38(1):2281262.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"152","key":"723_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107760","volume":"1","author":"WA Fadaly","year":"2024","unstructured":"Fadaly WA, Elshewy A, Nemr MT, Abdou K, Sayed AM, Kahk NM. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-\u03b3 agonists, \u03b1-glucosidase, \u03b1-amylase and COX-2 inhibitors; design, synthesis and in silico study. Bioorg Chem. 2024;1(152): 107760.","journal-title":"Bioorg Chem"},{"issue":"150","key":"723_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107623","volume":"1","author":"SY Ewieda","year":"2024","unstructured":"Ewieda SY, Hassan RA, Ahmed EM, Abdou AM, Hassan MS. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives. Bioorg Chem. 2024;1(150): 107623.","journal-title":"Bioorg Chem"},{"issue":"147","key":"723_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107403","volume":"1","author":"WA Fadaly","year":"2024","unstructured":"Fadaly WA, Nemr MT, Kahk NM. Discovery of novel pyrazole based urea\/thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities. Bioorg Chem. 2024;1(147): 107403.","journal-title":"Bioorg Chem"},{"issue":"4","key":"723_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22217","volume":"85","author":"WA Fadaly","year":"2024","unstructured":"Fadaly WA, Elshaier YA, Ali FE, El-Bahrawy AH, Abdellatif KR, Nemr MT. Vicinal diaryl pyrazole with tetrazole\/urea scaffolds as selective angiotensin converting enzyme-1\/cyclooxygenase-2 inhibitors: design, synthesis, anti-hypertensive, anti-fibrotic, and anti-inflammatory. Drug Dev Res. 2024;85(4): e22217.","journal-title":"Drug Dev Res"},{"issue":"134","key":"723_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106428","volume":"1","author":"WA Fadaly","year":"2023","unstructured":"Fadaly WA, Elshaier YA, Nemr MT, Abdellatif KR. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities. Bioorg Chem. 2023;1(134): 106428.","journal-title":"Bioorg Chem"},{"issue":"4 Suppl","key":"723_CR16","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","volume":"45","author":"F Rannou","year":"2016","unstructured":"Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S18-21.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"723_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0091270009336234","volume":"50","author":"JL Kienzler","year":"2010","unstructured":"Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol. 2010;50(1):50\u201361.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"723_CR18","first-page":"Cd007400","volume":"4","author":"S Derry","year":"2016","unstructured":"Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochr Database Syst Rev. 2016;4(4):Cd007400.","journal-title":"Cochr Database Syst Rev."},{"issue":"9","key":"723_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7326\/M19-3602","volume":"173","author":"A Qaseem","year":"2020","unstructured":"Qaseem A, McLean RM, O\u2019Gurek D, Batur P, Lin K, Kansagara DL, et al. Nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults: a clinical guideline from the American College of Physicians and American Academy of Family Physicians. Ann Intern Med. 2020;173(9):739\u201348.","journal-title":"Ann Intern Med"},{"key":"723_CR20","unstructured":"Voltaren Arthritis Pain [package insert]. Warren, NJ: GSK Consumer Health; 2020."},{"issue":"4","key":"723_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/03007995.2020.1716703","volume":"36","author":"PJ Wiffen","year":"2020","unstructured":"Wiffen PJ, Xia J. Systematic review of topical diclofenac for the treatment of acute and chronic musculoskeletal pain. Curr Med Res Opin. 2020;36(4):637\u201350.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"723_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40744-020-00196-6","volume":"7","author":"F Bariguian Revel","year":"2020","unstructured":"Bariguian Revel F, Fayet M, Hagen M. Topical diclofenac, an efficacious treatment for osteoarthritis: a narrative review. Rheumatol Ther. 2020;7(2):217\u201336.","journal-title":"Rheumatol Ther"},{"issue":"9","key":"723_CR23","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3899\/jrheum.081316","volume":"36","author":"RD Altman","year":"2009","unstructured":"Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(9):1991\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"723_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3810\/psm.2010.06.1779","volume":"38","author":"HS Baraf","year":"2010","unstructured":"Baraf HS, Gold MS, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed. 2010;38(2):19\u201328.","journal-title":"Phys Sportsmed"},{"issue":"3","key":"723_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2009.09.002","volume":"39","author":"HR Barthel","year":"2009","unstructured":"Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39(3):203\u201312.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"723_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.amjopharm.2011.12.002","volume":"10","author":"HS Baraf","year":"2012","unstructured":"Baraf HS, Gold MS, Petruschke RA, Wieman MS. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Am J Geriatr Pharmacother. 2012;10(1):47\u201360.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"723_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clinthera.2023.12.013","volume":"46","author":"TC K\u00fchler","year":"2024","unstructured":"K\u00fchler TC, Ateka A, Lassoued Z, Routhier FX, M\u00e9kary-Sawaya S. Real-world data and evidence to support a switch in status from prescription drug to over the counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM. Clin Ther. 2024;46(3):208\u201316.","journal-title":"Clin Ther"},{"issue":"2","key":"723_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7205\/MILMED-D-12-00168","volume":"178","author":"KA Dorrance","year":"2013","unstructured":"Dorrance KA, Ramchandani S, Neil N, Fisher H. Leveraging the military health system as a laboratory for health care reform. Mil Med. 2013;178(2):142\u20135.","journal-title":"Mil Med"},{"issue":"4","key":"723_CR29","doi-asserted-by":"publisher","DOI":"10.2196\/medinform.6437","volume":"4","author":"J Luo","year":"2016","unstructured":"Luo J, Eldredge C, Cho CC, Cisler RA. Population analysis of adverse events in different age groups using big clinical trials data. JMIR Med Inform. 2016;4(4): e30.","journal-title":"JMIR Med Inform"},{"issue":"4","key":"723_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1012848","volume":"366","author":"JD Berry","year":"2012","unstructured":"Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366(4):321\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"723_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCOUTCOMES.109.869727","volume":"3","author":"AK Marma","year":"2010","unstructured":"Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes. 2010;3(1):8\u201314.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"723_CR32","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690\u20137.","journal-title":"Arthritis Rheum"},{"key":"723_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/CIA.S35416","volume":"7","author":"JH Peniston","year":"2012","unstructured":"Peniston JH, Gold MS, Wieman MS, Alwine LK. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012;7:517\u201323.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"723_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/157340308784245775","volume":"4","author":"CB Zeller","year":"2008","unstructured":"Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008;4(2):116\u201322.","journal-title":"Curr Cardiol Rev"},{"issue":"10","key":"723_CR35","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/rheumatology\/kead646","volume":"63","author":"EC Jury","year":"2023","unstructured":"Jury EC, Peng J, Van Vijfeijken A, Martin Gutierrez L, Woodridge L, Wincup C, et al. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk. Rheumatology. 2023;63(10):2741\u201353.","journal-title":"Rheumatology."},{"key":"723_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/TCRM.S41931","volume":"9","author":"JH Peniston","year":"2013","unstructured":"Peniston JH, Gold MS, Wieman MS, Alwine LK. Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac. Ther Clin Risk Manag. 2013;9:153\u20139.","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"723_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.amjcard.2009.08.002","volume":"104","author":"RL Barkin","year":"2009","unstructured":"Barkin RL. Reducing cardiovascular risks of nonsteroidal anti-inflammatory drugs by using topical formulations. Am J Cardiol. 2009;104(9):1315.","journal-title":"Am J Cardiol"},{"issue":"10","key":"723_CR38","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.30498","volume":"63","author":"KL Cameron","year":"2011","unstructured":"Cameron KL, Hsiao MS, Owens BD, Burks R, Svoboda SJ. Incidence of physician-diagnosed osteoarthritis among active duty United States military service members. Arthritis Rheum. 2011;63(10):2974\u201382.","journal-title":"Arthritis Rheum"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00723-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:23:10Z","timestamp":1747459390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00723-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00723-9","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fr\u00e9d\u00e9rique Bariguian Revel, Richard Petruschke, Karin Nicholson and Francis Barbone are employees of Haleon, formerly GSK Consumer Healthcare. Nicholas M. Sicignano has no conflict of interests to declare. The sponsor, Haleon (Formerly GSK Consumer Healthcare), Warren, NJ, USA, participated in the study design, analysis, and interpretation. The sponsor also provided funding for medical writing support and participated in the decision to submit the manuscript for publication. The opinions and assertions expressed herein are those of the author(s) and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences or the Department of Defense. Neither Dr. Jess Edison nor any of his family members have a financial interest in any commercial product, service, or organization providing financial support for this research. References to non-Federal entities or products do not constitute or imply a Department of Defense or Uniformed Services University of the Health Sciences endorsement. This research protocol was reviewed and approved by the Naval Medical Center Portsmouth (IRB) in accordance with all applicable Federal regulations governing the protection of animals in research. This work was prepared by a military or civilian employee of the US Government as part of the individual\u2019s official duties and therefore is in the public domain and does not possess copyright protection (public domain information may be freely distributed and copied; however, as a courtesy it is requested that the Uniformed Services University and the author be given an appropriate acknowledgement). Research data were derived with oversight from Naval Medical Center, Portsmouth, VA, USA, IRB, NHRS identifier; number NMCP.2017.0096.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval from an Institutional Review Board (IRB) was obtained to access the DoD database. The study was conducted in accordance with the ethical principles laid down in the Declaration of Helsinki. All participants provided informed consent before study initiation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}